UK markets closed

AIM ImmunoTech Inc. (AIM)

NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
0.3890+0.0090 (+2.37%)
As of 03:09PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
135
-
141
135
163
140
Cost of revenue
176
-
0
850
806
893
Gross profit
-41
-
141
-715
-643
-753
Operating expenses
Research development
7,806
-
6,990
7,672
5,720
4,651
Selling general and administrative
12,186
-
13,074
8,672
8,654
7,039
Total operating expenses
19,992
-
20,064
16,344
14,374
11,690
Operating income or loss
-20,033
-
-19,923
-17,059
-15,017
-12,443
Interest expense
0
-
0
67
672
427
Total other income/expenses net
-1,065
-
-151
-2,001
1,289
3,377
Income before tax
-20,902
-
-19,445
-19,127
-14,400
-9,404
Income from continuing operations
-20,902
-
-19,445
-19,127
-14,400
-9,404
Net income
-20,902
-
-19,445
-19,127
-14,400
-9,404
Net income available to common shareholders
-20,902
-
-19,445
-19,127
-14,400
-9,404
Basic EPS
-0.43
-0.60
-0.40
-0.40
-0.45
-
Diluted EPS
-0.43
-0.60
-0.40
-0.40
-0.45
-
Basic average shares
48,383
48,585
48,047
47,340
31,843
-
Diluted average shares
48,383
48,585
48,047
47,340
31,843
-